Moderna Executive and Leadership Team

Jamey Mock, the Chief Financial Officer at Moderna, directs all financial strategy and operations. Overseeing fiscal planning, capital allocation, and investor relations, Mock ensures robust financial health and sustainable growth. This leadership role involves managing budgets, forecasting financial performance, and optimizing resource deployment across the organization. By driving financial discipline, Jamey Mock directly supports Moderna's mission to develop groundbreaking mRNA medicines. Ultimately, Mock secures the financial stability required for pioneering advancements in treating infectious diseases, cancer, rare disorders, and autoimmune conditions. The Chief Financial Officer's oversight extends to risk management and ensuring compliance with all financial regulations, thereby safeguarding the company's assets and reputation.

Kei Kaneda, the Representative Director & President at Moderna, leads the company's strategic direction and operational oversight. Overseeing all facets of the business, Kaneda drives innovation and ensures the effective execution of Moderna's mission to advance mRNA medicine. This executive role involves fostering a culture of scientific excellence and guiding the company through critical growth phases. By championing strategic initiatives, Kei Kaneda directly supports the development and delivery of transformative treatments for a range of diseases. The Representative Director & President's leadership is instrumental in navigating the complexities of the global pharmaceutical landscape. Kaneda's vision guides Moderna's commitment to improving human health worldwide.

Jeffrey Salling, the Chief of Staff & Operations Senior Director, Legal at Moderna, manages critical operational functions within the legal department. Overseeing day-to-day operations and strategic initiatives, Salling ensures the efficient execution of legal processes and supports the broader legal team's objectives. This role involves coordinating cross-functional projects and streamlining workflows to enhance productivity and compliance. By driving operational excellence, Jeffrey Salling directly contributes to Moderna's ability to navigate complex regulatory landscapes. The Chief of Staff & Operations Senior Director, Legal's focus on operational efficiency supports the company's mission to develop and deliver innovative mRNA-based medicines. Salling's efforts are vital for maintaining the integrity and effectiveness of Moderna's legal framework.

Michelle Patel, the Chief of Staff, Oncology at Moderna, spearheads strategic operations and cross-functional alignment within the oncology division. Overseeing key initiatives and ensuring seamless execution of the oncology pipeline, Patel drives progress in developing novel cancer treatments. This leadership position involves close collaboration with research, development, and commercial teams to accelerate therapeutic advancements. By fostering operational synergy, Michelle Patel directly supports Moderna's commitment to combating cancer through mRNA technology. The Chief of Staff, Oncology's role is crucial for translating scientific breakthroughs into tangible patient benefits. Patel's strategic oversight ensures that oncology programs advance efficiently towards clinical application and market readiness.

Michael Aihe, the Manager, Chief Marketing Officer Planning, Supply Chain at Moderna, directs strategic planning for supply chain operations. Overseeing the integration of marketing objectives with supply chain execution, Aihe ensures efficient product delivery and market responsiveness. This role involves optimizing logistics, managing inventory, and enhancing the flow of goods to meet global demand. By driving supply chain efficiency, Michael Aihe directly supports Moderna's ability to bring innovative mRNA medicines to patients worldwide. The Manager, Chief Marketing Officer Planning, Supply Chain's focus on operational excellence is critical for the timely distribution of vaccines and therapeutics. Aihe's planning ensures that Moderna's supply chain effectively supports its commercial strategies and global reach.

Paula Rodríguez, the Senior Chief Marketing Officer, Operations & Specialist at Moderna, leads strategic marketing operations and specialized initiatives. Overseeing the execution of marketing plans and ensuring operational readiness, Rodríguez enhances Moderna's market presence and engagement. This position involves coordinating marketing campaigns, analyzing market trends, and optimizing resource allocation for maximum impact. By driving strategic marketing execution, Paula Rodríguez directly contributes to the successful commercialization of mRNA-based therapies. The Senior Chief Marketing Officer, Operations & Specialist's expertise is vital for communicating the value of Moderna's innovations. Rodríguez's focus on specialized operations ensures targeted and effective outreach across diverse therapeutic areas.

Richard Mason, the Senior Specialist, External Manufacturing - Chief Marketing Officer Operations at Moderna, manages critical aspects of external manufacturing operations. Overseeing relationships with manufacturing partners and ensuring alignment with marketing strategies, Mason drives efficiency and quality in production. This role involves coordinating production schedules, managing supplier performance, and ensuring compliance with stringent industry standards. By optimizing external manufacturing, Richard Mason directly supports Moderna's capacity to produce life-changing mRNA medicines at scale. The Senior Specialist, External Manufacturing - Chief Marketing Officer Operations's focus on operational excellence is key to meeting global demand. Mason's expertise ensures reliable and high-quality production of therapeutics.

Sam Ismail, the Chief Marketing Officer & Senior Analyst at Moderna, directs marketing strategy and provides critical analytical insights. Overseeing market analysis, campaign development, and performance tracking, Ismail ensures data-driven decision-making across marketing functions. This role involves identifying market opportunities, evaluating competitive landscapes, and optimizing marketing investments for maximum return. By driving strategic marketing and analysis, Sam Ismail directly enhances Moderna's market penetration and brand recognition. The Chief Marketing Officer & Senior Analyst's dual focus ensures that marketing efforts are both innovative and grounded in rigorous data. Ismail's analytical approach supports the effective communication of Moderna's scientific advancements.

Sameh Ismail, the Chief Marketing Officer & Senior Analyst at Moderna, leads comprehensive marketing initiatives and deepens analytical capabilities. Overseeing the strategic planning and execution of marketing campaigns, Ismail ensures alignment with company objectives and market dynamics. This position involves leveraging advanced analytics to understand customer behavior and refine marketing approaches. By driving integrated marketing strategies, Sameh Ismail directly contributes to expanding access to Moderna's groundbreaking mRNA medicines. The Chief Marketing Officer & Senior Analyst's role is pivotal in translating scientific innovation into market success. Ismail's analytical rigor informs effective communication and engagement with key stakeholders globally.